Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-61,133
Closed -$357K 3388
2025
Q1
$357K Buy
+61,133
New +$322K 0.02% 1276
2024
Q4
Sell
-16,608
Closed -$92.8K 3076
2024
Q3
$92.8K Sell
16,608
-8,103
-33% -$56.7K 0.01% 1618
2024
Q2
$208K Buy
24,711
+11,323
+85% +$121K 0.02% 1208
2024
Q1
$193K Buy
+13,388
New +$221K 0.03% 1190
2023
Q4
Sell
-24,718
Closed -$475K 2249
2023
Q3
$475K Buy
24,718
+13,009
+111% +$277K 0.08% 432
2023
Q2
$298K Buy
+11,709
New +$338K 0.05% 732
2022
Q4
Sell
-4,332
Closed -$202K 1576
2022
Q3
$202K Buy
+4,332
New +$201K 0.05% 775
2022
Q2
Sell
-3,085
Closed -$223K 1156
2022
Q1
$223K Buy
+3,085
New +$222K 0.1% 376

Other funds holding NVRO

XTX Topco's NVRO Position: Q2 2025 in Review

XTX Topco sold out of NEVRO CORP. (NVRO) in Q2 2025, closing a stake of 61,133 shares — an estimated $357K sold.

XTX Topco first reported a position in NVRO in Q1 2022 and held it in 8 quarters. The position peaked at $475K in Q3 2023. 1 fund tracked by Wall St. Rank holds NVRO as of Q2 2025.

  • XTX Topco reported no remaining NEVRO CORP. position as of Q2 2025 after selling out during the quarter.
  • XTX Topco sold 61,133 NEVRO CORP. shares in Q2 2025, an estimated $357K.
  • XTX Topco first reported a position in NEVRO CORP. in Q1 2022 and held it in 8 quarters.
  • XTX Topco's NEVRO CORP. position peaked at $475K in Q3 2023.
  • 1 fund tracked by Wall St. Rank held NEVRO CORP. as of Q2 2025.

Based on XTX Topco's 13F filing for Q2 2025, filed 12 Aug 2025.